Key result
Syringaldehyde treatment in rats with isoproterenol-induced cardiotoxicity diminished serum marker enzymes, lipid peroxidation, and protein carbonyl levels while improving myocardial histopathology.
Why the study?
Does syringaldehyde protect against isoproterenol-induced cardiotoxicity in rats?
Does syringaldehyde protect against isoproterenol-induced cardiotoxicity in rats?
Syringaldehyde exhibits concentration-dependent cardioprotective effects against isoproterenol-induced myocardial injury in rats via antioxidant and anti-inflammatory mechanisms.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice; hypothesis-generating for syringaldehyde in animal cardiotoxicity models.
BACKGROUND: Ischemic injury during myocardial infarction (MI) is responsible for increased deaths among patients with cardiovascular disorders. Recently, research has been directed for finding treatment using natural compounds. This study was performed to investigate the effects of syrigaldehyde (SYD), a phytochemical against isoproterenol (ISO) induced cardiotoxicity model. METHODS: For induction of MI, rats were intoxicated with two doses of ISO and were treated with SYD at three different concentrations (12.5, 25 & 50 mg/kg) both prior and simultaneous to ISO administration. RESULTS: ISO group revealed amplified activity of marker enzymes (CKMB, LDH, AST, ALT), increased oxidation of proteins and lipid molecules. Moreover, augmentation in pro-inflammatory markers was also found. The same group also displayed marked changes in histopathology and erythrocyte (RBCs) morphology. SYD treated groups showed diminished levels of serum markers enzymes, lipid peroxidation and protein carbonyl (PC) with increment in antioxidant defense in cardiac tissues of ISO administered rats. Our findings also revealed the modulatory effect of SYD on membrane bound ATPases, showing that SYD significantly improved the ISO induced changes in membrane fluidity. Furthermore, decline in infarct size, alleviation of structural RBC damage and improved myocardial histopathological outcome were observed in treated groups. In addition, mitigation of biochemical and histopathological changes by SYD was found to be dependent on its concentration. CONCLUSION: SYD had cardioprotective efficacy owing to its antioxidative and anti-inflammatory properties. Our results support incorporation of SYD in regular diet for prevention of MI.
No takes yet. Share an insight, caveat, or question.
Shahzad et al. (2018) studied Isoproterenol-induced cardiotoxicity. Syringaldehyde (SYD) vs. Isoproterenol (ISO) alone was evaluated on Marker enzymes, lipid peroxidation, protein carbonyl, and histopathological changes. Syringaldehyde treatment in rats with isoproterenol-induced cardiotoxicity diminished serum marker enzymes, lipid peroxidation, and protein carbonyl levels while improving myocardial histopathology.
Synapse has enriched 10 related papers. Consider them for comparative context: